Abstract
Syed Adil Hassan, Kasturi Hazarika, Prashant Kumar Rai
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Incidence, prevalence, and mortality of dermatomyositis: a population-based cohort study
10.1002/acr.24786 · 2023
Risk of Malignancy in Dermatomyositis and Polymyositis
10.1177/1203475416665601 · 2017
10.1038/s41584-023-01045-w
10.1038/s41584-023-01045-w
Use of Anti-transcriptional Intermediary Factor-1 Gamma Autoantibody in Identifying Adult Dermatomyositis Patients with Cancer: A Systematic Review and Meta-analysis
10.2340/00015555-3091 · 2019
10.1177/014107688507800915
10.1177/014107688507800915
10.1097/01.smj.0000215732.28409.af
10.1097/01.smj.0000215732.28409.af
Amyopathic dermatomyositis associated with esophageal cancer
10.1111/j.1365-4632.2008.03486.x · 2008
Cancer-associated myositis associated with oesophageal adenocarcinoma arising in Barrett’s oesophagus without serum myogenic enzymes elevation: an example suggesting the importance of MRI
10.1136/bcr-2016-215047 · 2016
Dermatomyositis as a paraneoplastic phenomenon in oesophageal cancer
10.1136/bcr-2018-227387 · 2018
A Case of Dermatomyositis Along with Esophageal Cancer and Screening of Serum Transcriptional Intermediary Factor 1 Gamma Antibodies in Various Cancer Patients
10.12659/ajcr.922004 · 2020
Unveiling the complex nexus: dermatomyositis and esophageal adenocarcinoma—a case report
10.21037/aoe-23-23 · 2024
Incidence and Distinct Features of Immune Checkpoint Inhibitor-Related Myositis From Idiopathic Inflammatory Myositis: A Single-Center Experience With Systematic Literature Review and Meta-Analysis
10.3389/fimmu.2021.803410 · 2021
10.1136/annrheumdis-2017-211468
10.1136/annrheumdis-2017-211468
Dermatomyositis unleashed by immune checkpoint inhibitors. Three additional cases and a review of the literature
10.1016/j.autrev.2023.103375 · 2023
Anti-TIF1γ antibody-positive dermatomyositis associated with nivolumab administration in a patient with advanced oesophageal squamous cell carcinoma: A case report and literature review
10.1093/mrcr/rxad007 · 2023
10.1002/art.38093
10.1002/art.38093
10.1056/nejmra1402225
10.1056/nejmra1402225
Inflammatory Myopathies
10.1056/nejmra2415426 · 2026
Efficacy and Safety of Pembrolizumab for Heavily Pretreated Patients With Advanced, Metastatic Adenocarcinoma or Squamous Cell Carcinoma of the Esophagus: The Phase 2 KEYNOTE-180 Study
10.1001/jamaoncol.2018.5441 · 2019
10.1200/jco.20.01888
10.1200/jco.20.01888
No additional external references are available.